Quick Answer
OnKure Therapeutics, Inc. reported Stockholders Equity of $56.18 million for fiscal year 2025.
OnKure Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $56.18M | -45.9% |
| 2024 | $103.83M | +202.0% |
| 2023 | -$101.84M | -87.1% |
| 2022 | -$54.42M | -137.0% |
| 2021 | $147.21M | +449.5% |
| 2020 | -$42.12M | -82.1% |
| 2019 | -$23.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $66.43M | +149.2% | -15.0% |
| June 30, 2025 | $78.17M | +163.3% | -13.8% |
| March 31, 2025 | $90.65M | +181.5% | -12.7% |
| December 31, 2024 | $103.83M | +202.0% | +176.9% |
| September 30, 2024 | -$135.05M | -217.5% | -9.3% |
| June 30, 2024 | -$123.58M | -193.2% | -11.1% |
| March 31, 2024 | -$111.26M | -227.8% | -9.2% |
| December 31, 2023 | -$101.84M | -201.9% | -188.6% |
- OnKure Therapeutics, Inc. showed a decrease of -45.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, OnKure Therapeutics, Inc.’s stockholders equity has grown by 342.9% (from -$23.13 million to $56.18 million).
- The most recent figure is from OnKure Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: